SCHEMBL2373405

SCHEMBL2373405

COc1ccc(CNC(=O)c2csc(Nc3ccncn3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.58
CYP3A4 P08684 5/20 0.58
CYP2C9 P11712 5/20 0.58
CYP2C19 P33261 5/20 0.58
POLB P06746 2/20 0.58
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
MAPT P10636 5/20 0.53
CYP2D6 P10635 2/20 0.53
HTT P42858 2/20 0.53
ROCK2 O75116 1/20 0.51
ROCK1 Q13464 1/20 0.51
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.47
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CLK1 P49759 1/20 0.46
HPGDS O60760 1/20 0.45
GAA P10253 1/20 0.44
AMY1A P0DUB6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2373938 0.90 SMN1; SMN2 (0.53) CYP1A2CYP3A4CYP2C9CYP2C19POLB
SCHEMBL2373945 0.89 NAMPT (0.46) CYP1A2CYP3A4CYP2C9CYP2C19POLB
SCHEMBL24139180 0.89 SMN1; SMN2 (0.53) CYP1A2CYP3A4CYP2C9CYP2C19POLB
SCHEMBL31681838 0.89 ROCK1 (0.54) CYP3A4CYP2C9MAPTCYP2D6ROCK2
SCHEMBL2373426 0.89 ROCK1 (0.54) CYP3A4CYP2C9MAPTCYP2D6ROCK2
SCHEMBL29072859 0.86 MMP13 (0.48) SMN1; SMN2HTTROCK2ROCK1ALDH1A1
SCHEMBL669856 0.86 MMP13 (0.48) SMN1; SMN2HTTROCK2ROCK1ALDH1A1
SCHEMBL2374577 0.86 MPL (0.46) SMN1; SMN2ROCK2ROCK1HPGDSMAPK1
SCHEMBL12254348 0.85 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C9CYP2C19POLB
SCHEMBL2373434 0.84 TRPV4 (0.44) CYP1A2CYP3A4CYP2C9CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12410397-B2 Methods of enhancing cell survival of stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2025-09-09 US disclosed
EP-4585589-A2 STEM CELL CULTURES The Scripps Research Institute (US) 2025-07-16 EP disclosed
EP-4296270-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2025-06-18 EP disclosed
EP-4296270-A2 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3936508-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2023-12-06 EP disclosed
EP-4206319-A1 INDUCTION OF PLURIPOTENT CELLS The Scripps Research Institute (US) 2023-07-05 EP disclosed
EP-3235901-B1 INDUCTION OF PLURIPOTENT CELLS SCRIPPS RESEARCH INST (US) 2022-12-21 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
WO-2010065721-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294761-A1 STEM CELL CULTURES NES, CD44, MCL1 CYP1A2 4791/4885CYP3A4 4850/4885CYP2C9 4875/4885
US-12410397-B2 Methods of enhancing cell survival of stem cells MCL1, BCL2, BCLAF1 CYP1A2 4865/4885CYP3A4 4875/4885CYP2C9 4885/4885
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS MCL1, BCL2, BCLAF1 CYP1A2 4865/4885CYP3A4 4875/4885CYP2C9 4885/4885
US-20110224233-A1 STEM CELL CULTURES NES, CD44, MCL1 CYP1A2 4791/4885CYP3A4 4850/4885CYP2C9 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.